Herpes simplex infectious disease
MONDO:0004609A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)
Also known as: Simplexvirus caused disease or disorder, Simplexvirus disease or disorder, Simplexvirus infectious disease, herpes simplex, herpes simplex complex, herpes simplex infection, herpes simplex viral infection
38 clinical trials for this condition and its sub-types, 15 tagged with Herpes simplex infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Herpes simplex infectious disease
-
Genital herpes 8 trials
2 sub-types
-
Herpes simplex type 2 infectious disease 5 trials · 8 incl. sub-types
2 sub-types
-
Herpes labialis 5 trials
2 sub-types
-
2 sub-types
-
Herpes simplex virus keratitis 1 trial · 4 incl. sub-types
2 sub-types
- Endotheliitis 2 trials
- Stromal keratitis 1 trial
-
Herpes simplex encephalitis 2 trials
-
Herpes simplex dermatitis 0 trials
-
Herpetic whitlow 0 trials
-
New mRNA vaccine aims to shield transplant patients from dangerous virus
Vaccine OngoingThis study tests an mRNA vaccine (mRNA-1647) to prevent cytomegalovirus (CMV) infection in people who have had a stem cell transplant. About 84 participants will receive either the vaccine or a placebo. The goal is to see if the vaccine can safely prevent CMV after stopping stand…
Phase 2 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
New shingles vaccine trial aims for safer protection in adults 40+
Vaccine By invitation onlyThis early-stage trial tests a new shingles vaccine in 120 adults aged 40 and older. The main goal is to check safety and side effects at different doses, while also looking at how well the vaccine triggers an immune response. Participants receive either the vaccine or a placebo,…
Phase 1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: Vaccine
Last updated Jun 27, 2026 13:05 UTC
-
Experimental virus therapy for childhood brain tumors tested with radiation
Disease control CancelledThis study aimed to test an experimental virus therapy called G207, combined with a single dose of radiation, in children whose high-grade glioma had come back after prior treatment. The virus was injected directly into the brain tumor to kill cancer cells and trigger an immune r…
Phase 2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC